Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Hexyl/methyl aminolevulinate photodynamic therapy does not damage cervical tissue

July 21, 2010

Ziopharm begins phase III palifosfamide trial in metastatic soft tissue sarcoma

July 21, 2010

Geron begins phase II imetelstat trial in advanced non-small cell lung cancer

July 20, 2010

Jevtana launched in U.S. for metastatic hormone-refractory prostate cancer

July 20, 2010

Health Canada clears phase III ReoT3D trial in head and neck cancer

July 20, 2010

FDA approves Lorus Therapeutics' IND for anticancer agent LOR-253

July 20, 2010

Amgen's denosumab BLA receives FDA priority review status

July 19, 2010

Chinese scientists identify novel protein kinase inhibitors

July 19, 2010

Merck KGaA identifies new tyrosine kinase inhibitors

July 16, 2010

FDA grants orphan drug status to Keryx's perifosine for neuroblastoma

July 16, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...